Education
About Us
Working with TipRanks
Follow Us
Theriva Biologics (TOVX)
XASE:TOVX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -108.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ -87.00K |
| Operating Income | $ -15.02M | $ -26.35M | $ -21.43M | $ -21.58M | $ -14.27M |
| EBITDA | $ -14.91M | $ -19.29M | $ -21.96M | $ -19.20M | $ -14.19M |
| Net Income | $ -25.25M | $ -25.65M | $ -18.35M | $ -19.68M | $ -14.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.06M | $ 11.61M | $ 23.18M | $ 41.79M | $ 67.33M |
| Total Assets | $ 38.24M | $ 35.35M | $ 55.22M | $ 71.86M | $ 70.36M |
| Total Debt | $ 2.63M | $ 1.56M | $ 2.15M | $ 1.68M | $ 1.53M |
| Net Debt | $ -10.43M | $ -10.04M | $ -21.02M | $ -40.10M | $ -65.80M |
| Total Liabilities | $ 22.86M | $ 16.29M | $ 15.52M | $ 17.30M | $ 4.96M |
| Stockholders' Equity | $ 15.38M | $ 19.07M | $ 39.70M | $ 54.56M | $ 65.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -16.70M | $ -16.94M | $ -19.20M | $ -19.20M | $ -12.90M |
| Operating Cash Flow | $ -16.67M | $ -16.94M | $ -19.00M | $ -19.08M | $ -12.89M |
| Investing Cash Flow | $ -35.00K | $ -1.00K | $ -202.00K | $ -4.40M | $ -14.00K |
| Financing Cash Flow | $ 18.19M | $ 5.50M | $ 625.00K | $ -1.93M | $ 74.00M |